TeraRecon vs Ultromics EchoGo

A radiology department post-processing cardiac MR and CT is the TeraRecon buyer. Intuition covers cardiac MR flow, perfusion and strain, and the vendor says its AI Framework runs other vendors' algorithms. Own algorithms include Aorta.CT, cleared January 23, 2025, and Cardiovascular.Calcification.CT, cleared October 23, 2025, limited to GE or Siemens CT on the vendor's regulatory page. The AI Framework page mentions PACS integration and DICOM and HL7, naming no PACS vendor and no EHR. TeraRecon's home page and newsroom list no price.

A cardiology group running an echo lab is the Ultromics buyer. EchoGo Heart Failure, cleared September 23, 2024, reads one apical four-chamber clip for adults over 25 with an ejection fraction of 50% or higher. EchoGo Amyloidosis, cleared November 15, 2024, screens adults 65 and older with heart failure. The vendor cites 90.3% sensitivity and 86.1% specificity. A 2026 JACC Heart Failure analysis of 2,544 MESA participants reported an AUROC of 0.77 against 0.70 for H2FPEF in early HFpEF. Ultromics's home page offers "Talk with an EchoGo expert" instead of a price.

TeraRecon's pages cover CT and MR post-processing and Ultromics's cover transthoracic echocardiography, so a radiology department and an echo lab are separate buyers.